Search research articles
Contact Us
Filters
Showing results (311-320 of 332) with videos related to
Page
of 34
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2020
Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up
P Roth, A Pace, E Le Rhun, et al.
Science Signaling
|
July 2, 2009
Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis
Birgit Schoeberl, Emily A Pace, Jonathan B Fitzgerald, et al.
The Journal of Clinical Investigation
|
June 16, 2025
Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling
Jesse A Pace, Lauren M Goddard, Courtney C Hong, et al.
Annals of Neurology
|
October 1, 2008
Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity
Rishika A Pace, Rachel A Peat, Naomi L Baker, et al.
European Journal of Neurology
|
November 25, 2018
Stroke-like events after brain radiotherapy: a large series with long-term follow-up
A L Di Stefano, G Berzero, F Ducray, et al.
Dalton Transactions (Cambridge, England : 2003)
|
October 25, 2021
Using molten salts to probe outer-coordination sphere effects on lanthanide(III)/(II) electron-transfer reactions
Molly M MacInnes, Zachary R Jones, Bo Li, et al.
Cancer Causes & Control : CCC
|
January 17, 2026
Inflammation and insulin profiles in men assigned to exercise vs. usual care for prostate cancer: results from the active surveillance exercise (ASX) randomized controlled trial
William A Pace, Adam Olshen, Ye Wang, et al.
Cancer Immunology Research
|
January 6, 2025
NI-3201 Is a Bispecific Antibody Mediating PD-L1-Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control
Sara Majocchi, Pauline Lloveras, Lise Nouveau, et al.
Molecular Metabolism
|
October 9, 2021
Pharmacological blockade of the EP3 prostaglandin E<sub>2</sub> receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage
Karin J Bosma, Spencer R Andrei, Liora S Katz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2018
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer
Adam J Camblin, Emily A Pace, Sharlene Adams, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 332) with videos related to
Sort By:
Page
of 34
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2020
Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up
P Roth, A Pace, E Le Rhun, et al.
Science Signaling
|
July 2, 2009
Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis
Birgit Schoeberl, Emily A Pace, Jonathan B Fitzgerald, et al.
The Journal of Clinical Investigation
|
June 16, 2025
Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling
Jesse A Pace, Lauren M Goddard, Courtney C Hong, et al.
Annals of Neurology
|
October 1, 2008
Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity
Rishika A Pace, Rachel A Peat, Naomi L Baker, et al.
European Journal of Neurology
|
November 25, 2018
Stroke-like events after brain radiotherapy: a large series with long-term follow-up
A L Di Stefano, G Berzero, F Ducray, et al.
Dalton Transactions (Cambridge, England : 2003)
|
October 25, 2021
Using molten salts to probe outer-coordination sphere effects on lanthanide(III)/(II) electron-transfer reactions
Molly M MacInnes, Zachary R Jones, Bo Li, et al.
Cancer Causes & Control : CCC
|
January 17, 2026
Inflammation and insulin profiles in men assigned to exercise vs. usual care for prostate cancer: results from the active surveillance exercise (ASX) randomized controlled trial
William A Pace, Adam Olshen, Ye Wang, et al.
Cancer Immunology Research
|
January 6, 2025
NI-3201 Is a Bispecific Antibody Mediating PD-L1-Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control
Sara Majocchi, Pauline Lloveras, Lise Nouveau, et al.
Molecular Metabolism
|
October 9, 2021
Pharmacological blockade of the EP3 prostaglandin E<sub>2</sub> receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage
Karin J Bosma, Spencer R Andrei, Liora S Katz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2018
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer
Adam J Camblin, Emily A Pace, Sharlene Adams, et al.
Page
of 34